Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia

Molecular Pain

Volumn 9, Issue 1, 2013, Pages

  Prochazkova, Michaela ^a   Terse, Anita ^a   Amin, Niranjana D ^b   Hall, Bradford ^a   Utreras, Elias ^a,c   Pant, Harish C ^b   Kulkarni, Ashok B ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

Cdk5; Mouse model; Orofacial pain; p35; Trigeminal ganglia

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN P35;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FACE PAIN; HYPERALGESIA; HYPOALGESIA; LICKING; LOCOMOTION; MECHANICAL STIMULATION; MOTOR COORDINATION; MOUSE; MOUTH PAIN; NOCICEPTION; NONHUMAN; OROFACIAL PAIN; PRIORITY JOURNAL; REWARD; TRANSGENIC MOUSE; TRIGEMINUS GANGLION;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; FACIAL PAIN; HYPERALGESIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; TRIGEMINAL GANGLION;

EID: 84890534278     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-9-66     Document Type: Article

References (66)

1. Madland G, Newton-John T, Feinmann C. Chronic idiopathic orofacial pain: I: what is the evidence base?. Br Dent J 2001, 191:22-24.
2. Kohlmann T. Epidemiology of orofacial pain. Schmerz 2002, 16:339-345. 10.1007/s004820200000, 12235497.
3. Romero-Reyes M, Akerman S, Nguyen E, Vijjeswarapu A, Hom B, Dong HW, Charles AC. Spontaneous behavioral responses in the orofacial region: a model of trigeminal pain in mouse. Headache 2013, 53:137-151. 10.1111/j.1526-4610.2012.02226.x, 3664930, 22830495.
4. Yasuda M, Shinoda M, Kiyomoto M, Honda K, Suzuki A, Tamagawa T, Kaji K, Kimoto S, Iwata K. P2X3 receptor mediates ectopic mechanical allodynia with inflamed lower lip in mice. Neurosci Lett 2012, 528:67-72. 10.1016/j.neulet.2012.08.067, 22981884.
5. Poh KW, Lutfun N, Manikandan J, Ong WY, Yeo JF. Global gene expression analysis in the mouse brainstem after hyperalgesia induced by facial carrageenan injection-evidence for a form of neurovascular coupling?. Pain 2009, 142:133-141. 10.1016/j.pain.2008.12.029, 19167818.
6. Poh KW, Yeo JF, Stohler CS, Ong WY. Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception. J Neurosci 2012, 32:35-45. 10.1523/JNEUROSCI.2389-11.2012, 22219268.
7. Bornhof M, Ihmsen H, Schwilden H, Yeomans DC, Tzabazis A. The orofacial formalin test in mice revisited-effects of formalin concentration, age, morphine and analysis method. J Pain 2011, 12:633-639. 10.1016/j.jpain.2010.11.009, 21481645.
8. Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J Pain 2006, 7:908-914. 10.1016/j.jpain.2006.04.010, 17157777.
9. Miranda HF, Noriega V, Sierralta F, Prieto JC. Interaction between dexibuprofen and dexketoprofen in the orofacial formalin test in mice. Pharmacol Biochem Behav 2011, 97:423-427. 10.1016/j.pbb.2010.09.017, 20887749.
10. Miranda HF, Noriega V, Zepeda RJ, Sierralta F, Prieto JC. Systemic synergism between codeine and morphine in three pain models in mice. Pharmacol Rep 2013, 65:80-88.
11. Cha M, Kohan KJ, Zuo X, Ling JX, Gu JG. Assessment of chronic trigeminal neuropathic pain by the orofacial operant test in rats. Behav Brain Res 2012, 234:82-90. 10.1016/j.bbr.2012.06.020, 3418659, 22743005.
12. Krzyzanowska A, Pittolo S, Cabrerizo M, Sanchez-Lopez J, Krishnasamy S, Venero C, Avendano C. Assessing nociceptive sensitivity in mouse models of inflammatory and neuropathic trigeminal pain. J Neurosci Methods 2011, 201:46-54. 10.1016/j.jneumeth.2011.07.006, 21782847.
13. Rossi HL, Jenkins AC, Kaufman J, Bhattacharyya I, Caudle RM, Neubert JK. Characterization of bilateral trigeminal constriction injury using an operant facial pain assay. Neuroscience 2012, 224:294-306. 3468660, 22909425.
14. Teodoro FC, Tronco Junior MF, Zampronio AR, Martini AC, Rae GA, Chichorro JG. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models. Neuropeptides 2013, 47:199-206. 10.1016/j.npep.2012.10.005, 23177733.
15. Neubert JK, King C, Malphurs W, Wong F, Weaver JP, Jenkins AC, Rossi HL, Caudle RM. Characterization of mouse orofacial pain and the effects of lesioning TRPV1-expressing neurons on operant behavior. Mol Pain 2008, 4:43. 10.1186/1744-8069-4-43, 2584042, 18828909.
16. Neubert JK, Widmer CG, Malphurs W, Rossi HL, Vierck CJ, Caudle RM. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 2005, 116:386-395. 10.1016/j.pain.2005.05.011, 15982812.
17. Nolan TA, Hester J, Bokrand-Donatelli Y, Caudle RM, Neubert K. Adaptation of novel operant orofacial testing system to characterize both mechanical and thermal pain. Behav Brain Res 2011, 217:477-480. 10.1016/j.bbr.2010.10.022, 3010421, 20974188.
18. Rossi HL, Vierck CJ, Caudle RM, Neubert JK. Characterization of cold sensitivity and thermal preference using an operant orofacial assay. Mol Pain 2006, 2:37. 10.1186/1744-8069-2-37, 1764875, 17166284.
19. Dhariwala FA, Rajadhyaksha MS. An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol 2008, 28:351-369. 10.1007/s10571-007-9242-1, 18183483.
20. Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol 2001, 2:749-759. 10.1038/35096019, 11584302.
21. Lalioti V, Pulido D, Sandoval IV. Cdk5, the multifunctional surveyor. Cell Cycle 2010, 9:284-311. 10.4161/cc.9.2.10466, 20061803.
22. Liebl J, Furst R, Vollmar AM, Zahler S. Twice switched at birth: cell cycle-independent roles of the " neuron-specific" cyclin-dependent kinase 5 (Cdk5) in non-neuronal cells. Cell Signal 2011, 23:1698-1707. 10.1016/j.cellsig.2011.06.020, 21741478.
23. Su SC, Tsai LH. Cyclin-dependent kinases in brain development and disease. Annu Rev Cell Dev Biol 2011, 27:465-491. 10.1146/annurev-cellbio-092910-154023, 21740229.
24. Arif A. Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5. Biochem Pharmacol 2012, 84:985-993. 10.1016/j.bcp.2012.06.027, 22795893.
25. Contreras-Vallejos E, Utreras E, Gonzalez-Billault C. Going out of the brain: non-nervous system physiological and pathological functions of Cdk5. Cell Signal 2012, 24:44-52. 10.1016/j.cellsig.2011.08.022, 21924349.
26. Rosales JL, Lee KY. Extraneuronal roles of cyclin-dependent kinase 5. Bioessays 2006, 28:1023-1034. 10.1002/bies.20473, 16998837.
27. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 1996, 93:11173-11178. 10.1073/pnas.93.20.11173, 38303, 8855328.
28. Takahashi S, Ohshima T, Cho A, Sreenath T, Iadarola MJ, Pant HC, Kim Y, Nairn AC, Brady RO, Greengard P, Kulkarni AB. Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc Natl Acad Sci USA 2005, 102:1737-1742. 10.1073/pnas.0409456102, 547862, 15665076.
29. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 1997, 18:29-42. 10.1016/S0896-6273(01)80044-1, 9010203.
30. Pareek TK, Keller J, Kesavapany S, Agarwal N, Kuner R, Pant HC, Iadarola MJ, Brady RO, Kulkarni AB. Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1. Proc Natl Acad Sci USA 2007, 104:660-665. 10.1073/pnas.0609916104, 1752192, 17194758.
31. Yang YR, He Y, Zhang Y, Li Y, Li Y, Han Y, Zhu H, Wang Y. Activation of cyclin-dependent kinase 5 (Cdk5) in primary sensory and dorsal horn neurons by peripheral inflammation contributes to heat hyperalgesia. Pain 2007, 127:109-120. 10.1016/j.pain.2006.08.008, 16996690.
32. Pareek TK, Keller J, Kesavapany S, Pant HC, Iadarola MJ, Brady RO, Kulkarni AB. Cyclin-dependent kinase 5 activity regulates pain signaling. Proc Natl Acad Sci USA 2006, 103:791-796. 10.1073/pnas.0510405103, 1325969, 16407116.
33. Maccioni RB, Otth C, Concha II, Munoz JP. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur J Biochem 2001, 268:1518-1527. 10.1046/j.1432-1327.2001.02024.x, 11248668.
34. Langford DJ, Bailey AL, Chanda ML, Clarke SE, Drummond TE, Echols S, Glick S, Ingrao J, Klassen-Ross T, Lacroix-Fralish ML, et al. Coding of facial expressions of pain in the laboratory mouse. Nat Methods 2010, 7:447-449. 10.1038/nmeth.1455, 20453868.
35. Dolan JC, Lam DK, Achdjian SH, Schmidt BL. The dolognawmeter: a novel instrument and assay to quantify nociception in rodent models of orofacial pain. J Neurosci Methods 2010, 187:207-215. 10.1016/j.jneumeth.2010.01.012, 2832714, 20096303.
36. Ambalavanar R, Moritani M, Dessem D. Trigeminal P2X3 receptor expression differs from dorsal root ganglion and is modulated by deep tissue inflammation. Pain 2005, 117:280-291. 10.1016/j.pain.2005.06.029, 16153775.
37. Harriott AM, Gold MS. Serotonin type 1D receptors (5HTR) are differentially distributed in nerve fibres innervating craniofacial tissues. Cephalalgia 2008, 28:933-944. 10.1111/j.1468-2982.2008.01635.x, 2682350, 18557979.
38. Harriott AM, Gold MS. Electrophysiological properties of dural afferents in the absence and presence of inflammatory mediators. J Neurophysiol 2009, 101:3126-3134. 10.1152/jn.91339.2008, 2694126, 19339455.
39. Wang CH, Chou WY, Hung KS, Jawan B, Lu CN, Liu JK, Hung YP, Lee TH. Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin-induced nociceptive response in rats. Acta Pharmacol Sin 2005, 26:46-50. 10.1111/j.1745-7254.2005.00007.x, 15659113.
40. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824. 10.1038/39807, 9349813.
41. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, Raumann BE, Basbaum AI, Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998, 21:531-543. 10.1016/S0896-6273(00)80564-4, 9768840.
42. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313. 10.1126/science.288.5464.306, 10764638.
43. Xing BM, Yang YR, Du JX, Chen HJ, Qi C, Huang ZH, Zhang Y, Wang Y. Cyclin-dependent kinase 5 controls TRPV1 membrane trafficking and the heat sensitivity of nociceptors through KIF13B. J Neurosci 2012, 32:14709-14721. 10.1523/JNEUROSCI.1634-12.2012, 23077056.
44. Cui M, Honore P, Zhong C, Gauvin D, Mikusa J, Hernandez G, Chandran P, Gomtsyan A, Brown B, Bayburt EK, et al. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 2006, 26:9385-9393. 10.1523/JNEUROSCI.1246-06.2006, 16971522.
45. Watabiki T, Kiso T, Tsukamoto M, Aoki T, Matsuoka N. Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain. Biol Pharm Bull 2011, 34:1105-1108. 10.1248/bpb.34.1105, 21720020.
46. Yu L, Yang F, Luo H, Liu FY, Han JS, Xing GG, Wan Y. The role of TRPV1 in different subtypes of dorsal root ganglion neurons in rat chronic inflammatory nociception induced by complete Freund's adjuvant. Mol Pain 2008, 4:61. 10.1186/1744-8069-4-61, 2628345, 19055783.
47. Ro JY, Lee JS, Zhang Y. Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia. Pain 2009, 144:270-277. 10.1016/j.pain.2009.04.021, 2789550, 19464796.
48. Saloman JL, Chung MK, Ro JY. P2X (3) and TRPV1 functionally interact and mediate sensitization of trigeminal sensory neurons. Neuroscience 2012, 232:226-238.
49. Lee J, Saloman JL, Weiland G, Auh QS, Chung MK, Ro JY. Functional interactions between NMDA receptors and TRPV1 in trigeminal sensory neurons mediate mechanical hyperalgesia in the rat masseter muscle. Pain 2012, 153:1514-1524. 10.1016/j.pain.2012.04.015, 3377858, 22609428.
50. Kim SH, Ryan TA. CDK5 serves as a major control point in neurotransmitter release. Neuron 2010, 67:797-809. 10.1016/j.neuron.2010.08.003, 2939042, 20826311.
51. Kim SH, Ryan TA. Balance of calcineurin aalpha and CDK5 activities sets release probability at nerve terminals. J Neurosci 2013, 33:8937-8950. 10.1523/JNEUROSCI.4288-12.2013, 3808255, 23699505.
52. Zhang HH, Zhang XQ, Wang WY, Xue QS, Lu H, Huang JL, Gui T, Yu BW. Increased synaptophysin is involved in inflammation-induced heat hyperalgesia mediated by cyclin-dependent kinase 5 in rats. PLoS One 2012, 7:e46666. 10.1371/journal.pone.0046666, 3462774, 23056393.
53. Chen HJ, Xie WY, Hu F, Zhang Y, Wang J, Wang Y. Disruption of delta-opioid receptor phosphorylation at threonine 161 attenuates morphine tolerance in rats with CFA-induced inflammatory hypersensitivity. Neurosci Bull 2012, 28:182-192. 10.1007/s12264-012-1216-8, 22466129.
54. Xie WY, He Y, Yang YR, Li YF, Kang K, Xing BM, Wang Y. Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the delta-opioid receptor: impaired receptor function and attenuated morphine antinociceptive tolerance. J Neurosci 2009, 29:3551-3564. 10.1523/JNEUROSCI.0415-09.2009, 19295160.
55. Zhang R, Liu Y, Zhang J, Zheng Y, Gu X, Ma Z. Intrathecal administration of roscovitine attenuates cancer pain and inhibits the expression of NMDA receptor 2B subunit mRNA. Pharmacol Biochem Behav 2012, 102:139-145. 10.1016/j.pbb.2012.03.025, 22503970.
56. Zhang S, Edelmann L, Liu J, Crandall JE, Morabito MA. Cdk5 regulates the phosphorylation of tyrosine 1472 NR2B and the surface expression of NMDA receptors. J Neurosci 2008, 28:415-424. 10.1523/JNEUROSCI.1900-07.2008, 18184784.
57. Nair A, Simonetti M, Fabbretti E, Nistri A. The Cdk5 kinase downregulates ATP-gated ionotropic P2X3 receptor function via serine phosphorylation. Cell Mol Neurobiol 2010, 30:505-509. 10.1007/s10571-009-9483-2, 19960242.
58. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui H. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 2002, 22:2590-2597.
59. Brierley SM, Castro J, Harrington AM, Hughes PA, Page AJ, Rychkov GY, Blackshaw LA. TRPA1 contributes to specific mechanically activated currents and sensory neuron mechanical hypersensitivity. J Physiol 2011, 589:3575-3593. 10.1113/jphysiol.2011.206789, 3167119, 21558163.
60. Brierley SM, Hughes PA, Page AJ, Kwan KY, Martin CM, O'Donnell TA, Cooper NJ, Harrington AM, Adam B, Liebregts T, et al. The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology 2009, 137:2084-2095. e2083, 10.1053/j.gastro.2009.07.048, 2789877, 19632231.
61. Kwan KY, Glazer JM, Corey DP, Rice FL, Stucky CL. TRPA1 modulates mechanotransduction in cutaneous sensory neurons. J Neurosci 2009, 29:4808-4819. 10.1523/JNEUROSCI.5380-08.2009, 2744291, 19369549.
62. Alloui A, Zimmermann K, Mamet J, Duprat F, Noel J, Chemin J, Guy N, Blondeau N, Voilley N, Rubat-Coudert C, et al. TREK-1, a K + channel involved in polymodal pain perception. EMBO J 2006, 25:2368-2376. 10.1038/sj.emboj.7601116, 1478167, 16675954.
63. Dedman A, Sharif-Naeini R, Folgering JH, Duprat F, Patel A, Honore E. The mechano-gated K (2P) channel TREK-1. Eur Biophys J 2009, 38:293-303. 10.1007/s00249-008-0318-8, 18369610.
64. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
65. Nolan TA, Caudle RM, Neubert JK. Effect of caloric and non-caloric sweet reward solutions on thermal facial operant conditioning. Behav Brain Res 2011, 216:723-725. 10.1016/j.bbr.2010.08.023, 2981637, 20797411.
66. Veeranna A, Shetty KT, Amin N, Grant P, Albers RW, Pant HC. Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18. Neurochem Res 1996, 21:629-636. 10.1007/BF02527763, 8726973.